Connecting the world with CAR-T innovation in China
CartCellsChina.com is a specialized platform dedicated to sharing the latest developments in CAR-T cell therapy in China and helping international patients access advanced treatment opportunities. Powered by Gene Medical, a China-based medical facilitation company with extensive experience in international healthcare services, our platform serves as a bridge between global patients and China’s rapidly advancing cell therapy ecosystem.
Our mission is simple: to make cutting-edge CAR-T cell therapies and related medical innovations more accessible to patients worldwide while promoting greater awareness of the remarkable progress taking place in China’s biomedical sector.
Why China matters in CAR-T cell therapy
Over the past decade, China has emerged as one of the world’s leading centers for cell and gene therapy research and development. Today, China has the largest number of approved CAR-T cell therapy products globally and continues to lead in clinical trials, scientific publications, and innovative treatment approaches.
China has achieved several important milestones in the field, including the approval of the world’s first CAR-T cell therapy for solid tumors targeting Claudin18.2-positive gastric cancer and gastroesophageal junction cancer. Chinese hospitals, biotechnology companies, and research institutions continue to advance CAR-T technologies for hematologic malignancies, solid tumors, and even autoimmune diseases.
Despite these achievements, much of this information remains inaccessible to patients, caregivers, and healthcare professionals outside China due to language barriers and limited international exposure. CartCellsChina.com was created to help bridge this information gap.
What we do
CartCellsChina.com provides educational resources, treatment information, research updates, and practical guidance for international patients seeking CAR-T cell therapy in China.
Our services include:
- Sharing the latest CAR-T clinical research, approvals, and treatment developments from China
- Providing information about approved CAR-T products and emerging therapies
- Connecting patients with leading hospitals, physicians, and treatment centers
- Assisting with medical record review and treatment eligibility assessment
- Facilitating communication between international patients and Chinese medical teams
- Coordinating medical consultations and treatment planning
- Supporting patients with travel arrangements, visa documentation, accommodation, interpretation, and other logistics
Our goal is to help patients make informed decisions and navigate the treatment process with confidence.
Experience serving international patients
Since 2006, our team has helped more than 3,000 international patients travel to China for advanced medical care, including cell-based therapies.
2006
Experience since
3,000
Patients helped
9
CAR-T Therapies
We work with leading hospitals and medical experts in major healthcare hubs such as Beijing, Shanghai, Guangzhou, Shenzhen, and Tianjin. Through our network of healthcare providers, researchers, and industry partners, we strive to identify the most appropriate treatment options for each patient’s unique condition.
Every patient journey is different. Our role is to provide reliable information, facilitate communication, and help patients access the healthcare resources best suited to their needs.
Connecting patients and innovators
CAR-T cell therapy represents one of the most significant advances in modern cancer treatment. As new therapies continue to emerge, international collaboration becomes increasingly important.
We believe patients should have access to information about promising treatment options regardless of geographical boundaries. By connecting patients, physicians, researchers, hospitals, and biotechnology innovators, we hope to contribute to a more informed and connected global healthcare community.
Whether you are a patient, family member, physician, researcher, or healthcare professional, we welcome you to explore the resources available on our platform.
Contact us
If you are interested in a specific CAR-T cell therapy, clinical trial, research program, or treatment option for a particular disease, please contact us. Our team will do our best to help you identify relevant hospitals, physicians, research groups, or treatment opportunities in China.
Together, we can help bring innovative CAR-T cell therapies closer to patients who need them.